ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Summit Pharmaceuticals Europe Limited

Summit Pharmaceuticals Europe Limited is a converted/closed company incorporated on 16 May 2001 with the registered office located in London, City of London. Summit Pharmaceuticals Europe Limited was registered 24 years ago.
Status
Converted/closed
Company No
04217656
Converted / closed
Age
24 years
Incorporated 16 May 2001
Size
Small
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Submitted
For period 1 Apr ⟶ 31 Mar 2020 (1 year)
Accounts type is Full
Next accounts for period 31 March 2021
Was due on 31 December 2021 (3 years ago)
Learn more about Summit Pharmaceuticals Europe Limited
Contact Update Details
Address
Vintners' Place
68 Upper Thames Street
London
EC4V 3BJ
Same address for the past 7 years
Telephone
02072463600
Email
Unreported
See All Contacts
People
Officers
6
Shareholders
3
Controllers (PSC)
2
Toshiya Kitamura
Director • Business Man • Japanese • Lives in Japan • Born in Jul 1965
Harumasa Morizumi
Director • Japanese • Lives in Japan • Born in Aug 1967
Mr Yoshiaki Miyamoto
Director • Businessman • Japanese • Lives in Japan • Born in Nov 1977
Mr Takahiro Nishihara
Director • Japanese • Lives in Germany • Born in Oct 1962
Mr Takashi Yamana
Director • Ceo • Japanese • Lives in England • Born in Oct 1963
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Sumitomo Corporation Global Commodities Limited
Sumitomo Corporation Europe Ltd is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2011–2020)
Period Ended
31 Mar 2020
For period 31 Mar ⟶ 31 Mar 2020
Traded for 12 months
Cash in Bank
£86K
Increased by £66K (+330%)
Turnover
£27.68M
Increased by £2.26M (+9%)
Employees
36
Decreased by 1 (-3%)
Total Assets
£16.66M
Decreased by £1.05M (-6%)
Total Liabilities
-£11.74M
Decreased by £1.76M (-13%)
Net Assets
£4.92M
Increased by £709K (+17%)
Debt Ratio (%)
70%
Decreased by 5.76% (-8%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
5 Years Ago on 27 Oct 2020
Confirmation Submitted
5 Years Ago on 27 May 2020
Mr Yoshiaki Miyamoto Details Changed
5 Years Ago on 4 Feb 2020
Toshiya Kitamura Details Changed
5 Years Ago on 4 Feb 2020
Yoshiki Terawaki Resigned
5 Years Ago on 27 Jan 2020
Full Accounts Submitted
5 Years Ago on 21 Nov 2019
Confirmation Submitted
6 Years Ago on 17 May 2019
Harumasa Morizumi Appointed
6 Years Ago on 1 Jan 2019
Kenichi Nakamura Resigned
6 Years Ago on 1 Jan 2019
Full Accounts Submitted
7 Years Ago on 10 Sep 2018
Get Alerts
Get Credit Report
Discover Summit Pharmaceuticals Europe Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Miscellaneous
Submitted on 4 Dec 2020
Miscellaneous
Submitted on 4 Dec 2020
Full accounts made up to 31 March 2020
Submitted on 27 Oct 2020
Miscellaneous
Submitted on 24 Aug 2020
Confirmation statement made on 16 May 2020 with no updates
Submitted on 27 May 2020
Director's details changed for Toshiya Kitamura on 4 February 2020
Submitted on 6 Feb 2020
Director's details changed for Mr Yoshiaki Miyamoto on 4 February 2020
Submitted on 6 Feb 2020
Termination of appointment of Yoshiki Terawaki as a director on 27 January 2020
Submitted on 4 Feb 2020
Full accounts made up to 31 March 2019
Submitted on 21 Nov 2019
Confirmation statement made on 16 May 2019 with no updates
Submitted on 17 May 2019
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs